SciCombinator

Discover the most talked about and latest scientific content & concepts.

TM Lu, TS Lee, SJ Lin, WL Chan and CP Hsu
Abstract
The pathophysiology of cardiac syndrome X is multifactorial and endothelial dysfunction has been implicated as important contributing factor. Asymmetric dimethylarginine (ADMA), characterized as a circulating endogenous inhibitor of nitric oxide synthase, may have been implicated as an important contributing factor for the development of endothelial dysfunction. In this study, we aim to assess the predictive power of ADMA for long-term prognosis in patients with cardiac syndrome X.
Tweets*
0
Facebook likes*
0
Reddit*
0
News coverage*
0
Blogs*
0
SC clicks
1
Concepts
Asymmetric dimethylarginine, Cardiac syndrome X, Syndrome X, Prognosis, Arginine, Nitric oxide, Endothelium
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com